SCYNEXIS SCYX Stock
SCYNEXIS Price Chart
SCYNEXIS SCYX Financial and Trading Overview
| SCYNEXIS stock price | 4.39 USD |
| Previous Close | 4.84 USD |
| Open | 4.85 USD |
| Bid | 3.49 USD x 200 |
| Ask | 5.93 USD x 200 |
| Day's Range | 4.57 - 4.97 USD |
| 52 Week Range | 3.53 - 9.52 USD |
| Volume | 47.59K USD |
| Avg. Volume | 136.4K USD |
| Market Cap | 45.77M USD |
| Beta (5Y Monthly) | 1.109 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.91 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 36.55 USD |
SCYX Valuation Measures
| Enterprise Value | -6369798 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.987041 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.3817756 |
| Price/Book (mrq) | 0.6838115 |
| Enterprise Value/Revenue | -0.331 |
| Enterprise Value/EBITDA | N/A |
Trading Information
SCYNEXIS Stock Price History
| Beta (5Y Monthly) | 1.109 |
| 52-Week Change | -47.72% |
| S&P500 52-Week Change | 15.18% |
| 52 Week High | 9.52 USD |
| 52 Week Low | 3.53 USD |
| 50-Day Moving Average | 4.79 USD |
| 200-Day Moving Average | 5.69 USD |
SCYX Share Statistics
| Avg. Volume (3 month) | 136.4K USD |
| Avg. Daily Volume (10-Days) | 46.28K USD |
| Shares Outstanding | 9.95M |
| Float | 7.36M |
| Short Ratio | 1.81 |
| % Held by Insiders | 1.99% |
| % Held by Institutions | 61.95% |
| Shares Short | 454.01K |
| Short % of Float | 4.65% |
| Short % of Shares Outstanding | 4.56% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -53.26% |
| Operating Margin (ttm) | -3308.51% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.82% |
| Return on Equity (ttm) | -18.37% |
Income Statement
| Revenue (ttm) | 19.22M USD |
| Revenue Per Share (ttm) | 2.5 USD |
| Quarterly Revenue Growth (yoy) | -82.79% |
| Gross Profit (ttm) | 19.22M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -10235000 USD |
| Diluted EPS (ttm) | -0.91 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 54.08M USD |
| Total Cash Per Share (mrq) | 5.44 USD |
| Total Debt (mrq) | 1.95M USD |
| Total Debt/Equity (mrq) | 2.91 USD |
| Current Ratio (mrq) | 9.654 |
| Book Value Per Share (mrq) | 6.727 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -13309000 USD |
| Levered Free Cash Flow (ttm) | -7323375 USD |
Profile of SCYNEXIS
| Country | United States |
| State | NJ |
| City | Jersey City |
| Address | 1 Evertrust Plaza |
| ZIP | 07302-6548 |
| Phone | 201 884 5485 |
| Website | https://www.scynexis.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 18 |
SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence. It also develops SCY-247, which is in Phase I clinical trial for the treatment of invasive fungal infections. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.
Q&A For SCYNEXIS Stock
What is a current SCYX stock price?
SCYNEXIS SCYX stock price today per share is 4.39 USD.
How to purchase SCYNEXIS stock?
You can buy SCYX shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SCYNEXIS?
The stock symbol or ticker of SCYNEXIS is SCYX.
Which industry does the SCYNEXIS company belong to?
The SCYNEXIS industry is Drug Manufacturers - Specialty & Generic.
How many shares does SCYNEXIS have in circulation?
The max supply of SCYNEXIS shares is 9.95M.
What is SCYNEXIS Price to Earnings Ratio (PE Ratio)?
SCYNEXIS PE Ratio is now.
What was SCYNEXIS earnings per share over the trailing 12 months (TTM)?
SCYNEXIS EPS is -0.91 USD over the trailing 12 months.
Which sector does the SCYNEXIS company belong to?
The SCYNEXIS sector is Healthcare.
SCYNEXIS SCYX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25981.57 USD — |
-0.78
|
7B USD — | 25943.31 USD — | 26172.12 USD — | — - | 7B USD — |
|
US Tech Composite Total Return
XCMP
US
|
32087.45 USD — |
-0.78
|
— — | 32040.2 USD — | 32322.77 USD — | — - | — — |
|
US Tech Global Market Composite
NQGM
US
|
2179.37 USD — |
-1.51
|
— — | 2176.53 USD — | 2211.26 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1294.5 USD — |
-1.07
|
— — | 1285.37 USD — | 1305.11 USD — | — - | — — |
- {{ link.label }} {{link}}
